Our in vitro studies using a neurocytoma primary culture harboring mutations resulting in loss of PHF14 function demonstrated that restoration of PHF14 function by wild-type PHF14 transfection led to reduced primary neurocytoma cell viability and the PHF14 neurocytoma cell transfectants exhibited greater sensitivity to Sunitinib treatment. Here, PHF14 is linked to central neurocytoma.